GST rate amendments update classifications, adding specified medicines, extruded savoury snacks and motor vehicle seats to revised schedules. Jharkhand amends its State GST rate notification by inserting Trastuzumab Deruxtecan, Osimertinib and Durvalumab into the 2.5% list; adding an HS entry for extruded or expanded savoury or salted products (excluding certain un fried/uncooked extrusion manufactured pellets) to the 6% schedule; expanding the 9% schedule descriptions to cover extruded or expanded savoury/salted products and substituting the seats entry to exclude seats of heading 9402 and seats used in aircraft or motor vehicles; and adding motor vehicle seats (HS 9401 20 00) to the 14% schedule, effective from 10 October 2024.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
GST rate amendments update classifications, adding specified medicines, extruded savoury snacks and motor vehicle seats to revised schedules.
Jharkhand amends its State GST rate notification by inserting Trastuzumab Deruxtecan, Osimertinib and Durvalumab into the 2.5% list; adding an HS entry for extruded or expanded savoury or salted products (excluding certain un fried/uncooked extrusion manufactured pellets) to the 6% schedule; expanding the 9% schedule descriptions to cover extruded or expanded savoury/salted products and substituting the seats entry to exclude seats of heading 9402 and seats used in aircraft or motor vehicles; and adding motor vehicle seats (HS 9401 20 00) to the 14% schedule, effective from 10 October 2024.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
